TrialScope has received more than $10 million in funding. Edison Ventures led the round with participation from Dublin Capital Partners and NewSpring Capital. According to the firm, the capital will be used for growth and to fund its acquisition of Deloitte Analytics LLC assets. In addition to the funding and acquisition, James C. Walker, founder of Octagon Research, which is backed by Edison Ventures, and Michael Balmuth have been appointed to TrialScope’s board of directors. Based in Jersey City, NJ, TrialScope is a provider of clinical trial solutions.